David Tomoaki Miyamoto

Title: Innovations by David Tomoaki Miyamoto

Introduction

David Tomoaki Miyamoto is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of cancer research through his innovative patents. With a total of five patents to his name, Miyamoto's work focuses on advanced methods for analyzing blood samples to improve cancer therapy outcomes.

Latest Patents

Miyamoto's latest patents include groundbreaking technologies for the digital analysis of blood samples. One of his notable inventions is a method for analyzing RNA from circulating tumor cells (CTCs) and tumor-specific exosomes. This method aims to determine the expression levels of lineage markers in blood samples, which can predict progression-free survival and overall survival for specific anti-cancer treatment regimens. Another significant patent involves the digital analysis of circulating tumor cells in blood samples, which provides ultra-high sensitivity and specificity for early detection and monitoring of cancer. This method utilizes microfluidic isolation of CTCs and digital detection of RNA derived from these cells.

Career Highlights

Miyamoto is associated with The General Hospital Corporation, where he continues to advance his research and innovations. His work has been instrumental in developing new assay methods that enhance the understanding and treatment of cancer.

Collaborations

Some of his notable coworkers include Daniel Arie Haber and Shyamala Maheswaran, who collaborate with him on various research projects.

Conclusion

David Tomoaki Miyamoto's contributions to cancer research through his innovative patents demonstrate his commitment to improving patient outcomes. His work in digital analysis of blood samples is paving the way for more effective cancer therapies.